The first clinical trial of beta-calcium pyrophosphate as a novel bone graft extender in instrumented posterolateral lumbar fusion
- PMID: 21909472
- PMCID: PMC3162205
- DOI: 10.4055/cios.2011.3.3.238
The first clinical trial of beta-calcium pyrophosphate as a novel bone graft extender in instrumented posterolateral lumbar fusion
Abstract
Background: Porous β-calcium pyrophosphate (β-CPP) was developed to improve the fusion success of posterolateral lumbar fusion (PLF). The possibility of accomplishing PLF using a mixture of porous β-CPP and iliac bone was studied. This paper reports the radiologic results of PLF using the β-CPP plus autograft for lumbar degenerative disease as a bone graft extender.
Methods: A prospective, case-matched, radiographic study evaluating the results of short segment lumbar fusion using a β-CPP plus autograft was performed to compare the efficacy of β-CPP plus autograft with that of an autograft alone for short segment lumbar fusion. Thirty one consecutive patients (46 levels) underwent posterolateral fusion with pedicle screw fixation and additional posterior lumbar interbody fusion. In all patients, 3 mL of β-CPP plus 3 mL of autogenous bone graft was placed randomly in one side of a posterolateral gutter, and 6 mL of autogenous iliac bone graft was placed on the other. The fusion rates, volumes of fusion masses, and bone absorption percentage were evaluated postoperatively using simple radiographs and 3 dimensional computed tomography (3D-CT) scans.
Results: The control sides treated with an autograft showed significantly better Lenke scores than the study sides treated with β-CPP at 3 and 6 months postoperatively, but there was no difference between the two sides at 12 months. The fusion rates (confirmed by 3D-CT) were 87.0% in the β-CPP group and 89.1% in the autograft group, which were not significantly different. The fusion mass volumes and bone absorption percentage at 12 months postoperatively were 2.49 mL (58.4%) and 1.89 mL (69.5%) for the β-CPP and autograft groups, respectively, and mean fusion mass volume was significantly higher in the β-CPP group.
Conclusions: β-CPP combined with an autograft is as effective as autologous bone for grafting during instrumented posterolateral spinal fusion. These findings suggest that β-CPP bone chips can be used as a novel bone graft extender for short-segment posterolateral spinal fusion.
Keywords: Beta-calcium pyrophosphate; Bone graft extender; Fusion rate; Lumbar posterolateral fusion; Prospective consecutive study.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures


Similar articles
-
A prospective consecutive study of instrumented posterolateral lumbar fusion using synthetic hydroxyapatite (Bongros-HA) as a bone graft extender.J Biomed Mater Res A. 2009 Sep 1;90(3):804-10. doi: 10.1002/jbm.a.32113. J Biomed Mater Res A. 2009. PMID: 18615472 Clinical Trial.
-
Single-level instrumented posterolateral fusion of lumbar spine with beta-tricalcium phosphate versus autograft: a prospective, randomized study with 3-year follow-up.Spine (Phila Pa 1976). 2008 May 20;33(12):1299-304. doi: 10.1097/BRS.0b013e3181732a8e. Spine (Phila Pa 1976). 2008. PMID: 18496340 Clinical Trial.
-
The efficacy of a nanosynthetic bone graft substitute as a bone graft extender in rabbit posterolateral fusion.Spine J. 2021 Nov;21(11):1925-1937. doi: 10.1016/j.spinee.2021.05.017. Epub 2021 May 23. Spine J. 2021. PMID: 34033931
-
Graft options in posterolateral and posterior interbody lumbar fusion.Spine (Phila Pa 1976). 2010 Aug 1;35(17):1629-39. doi: 10.1097/BRS.0b013e3181d25803. Spine (Phila Pa 1976). 2010. PMID: 20628336 Review.
-
Experimental posterolateral lumbar spinal fusion with a demineralized bone matrix gel.Spine (Phila Pa 1976). 1998 Jan 15;23(2):159-67. doi: 10.1097/00007632-199801150-00003. Spine (Phila Pa 1976). 1998. PMID: 9474720 Review.
Cited by
-
Effectiveness and Feasibility of Injectable Escherichia coli-Derived Recombinant Human Bone Morphogenetic Protein-2 for Anterior Lumbar Interbody Fusion at the Lumbosacral Junction in Adult Spinal Deformity Surgery: A Clinical Pilot Study.Orthop Surg. 2022 Jul;14(7):1350-1358. doi: 10.1111/os.13303. Epub 2022 May 27. Orthop Surg. 2022. PMID: 35633034 Free PMC article. Clinical Trial.
-
Effects of porous beta-tricalcium phosphate-based ceramics used as an E. coli-derived rhBMP-2 carrier for bone regeneration.J Mater Sci Mater Med. 2013 Sep;24(9):2117-27. doi: 10.1007/s10856-013-4967-5. Epub 2013 Jun 1. J Mater Sci Mater Med. 2013. PMID: 23728522
-
Poly(Thioketal Urethane) Autograft Extenders in an Intertransverse Process Model of Bone Formation.Tissue Eng Part A. 2019 Jul;25(13-14):949-963. doi: 10.1089/ten.TEA.2018.0223. Epub 2019 Jan 9. Tissue Eng Part A. 2019. PMID: 30398387 Free PMC article.
-
Fabrication and evaluation of porous beta-tricalcium phosphate/hydroxyapatite (60/40) composite as a bone graft extender using rat calvarial bone defect model.ScientificWorldJournal. 2013 Dec 17;2013:481789. doi: 10.1155/2013/481789. eCollection 2013. ScientificWorldJournal. 2013. PMID: 24453864 Free PMC article.
-
Effect of Whitlockite as a new bone substitute for bone formation in spinal fusion and ectopic ossification animal model.Biomater Res. 2021 Oct 21;25(1):34. doi: 10.1186/s40824-021-00237-3. Biomater Res. 2021. PMID: 34674765 Free PMC article.
References
-
- Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res. 1996;(329):300–309. - PubMed
-
- Goulet JA, Senunas LE, DeSilva GL, Greenfield ML. Autogenous iliac crest bone graft: complications and functional assessment. Clin Orthop Relat Res. 1997;(339):76–81. - PubMed
-
- Banwart JC, Asher MA, Hassanein RS. Iliac crest bone graft harvest donor site morbidity: a statistical evaluation. Spine (Phila Pa 1976) 1995;20(9):1055–1060. - PubMed
-
- Boden SD, Grob D, Damien C. Ne-Osteo bone growth factor for posterolateral lumbar spine fusion: results from a nonhuman primate study and a prospective human clinical pilot study. Spine (Phila Pa 1976) 2004;29(5):504–514. - PubMed
-
- Lee JH, Lee DH, Ryu HS, Chang BS, Hong KS, Lee CK. Porous beta-calcium pyrophosphate as a bone graft substitute in a canine bone defect model. Key Eng Mater. 2003;240-2:399–402.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical